Tamar Weinberger is a Rheumatology/Immunology physician. OpenAlex indexes 17 publications with 334 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Gustave L. Levy Pl
New York, NY 10029
Telephone
212-241-5548Registry record last updated 21 Nov 2019.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARS Pharmaceuticals Operations, Inc.Program year20255 payments
- Regeneron Healthcare Solutions, Inc.Program year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
64.5%Leukotriene Receptor Antagonist35.1%Montelukast Sodium100%Part D≥22 patientsCorticosteroid20.4%Fluticasone Propionate100%Part D≥13 patients+ 1 more class in this area
Anti-infectives
11.4%Macrolide Antimicrobial11.4%Azithromycin100%Part D<11 patientsNervous system
7.6%Gabapentinoids7.6%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pitfalls of genetic testing in a patient with IKBKG deficiency
Annals of Allergy Asthma & Immunology
2024 - A Retrospective Review of Immediate Hypersensitivity Skin Testing and Graded Challenge to TMP-SMX for IgE-Mediated Sulfonamide Antibiotic Allergy
Journal of Allergy and Clinical Immunology
2022 - Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency
Journal of Clinical Immunology
2019 - A randomized controlled trial to reduce food allergy anxiety about casual exposure by holding the allergen: TOUCH study
The Journal of Allergy and Clinical Immunology In Practice
2019
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”